Understanding the human metagenome's role in metabolic diseases
Official title: Understanding the Role of the Human Metagenome in Obesity, Metabolic Diseases, Chronic Inflammation, Sarcopenia and Sarcopenic Obesity - a Pilot Study
Run by Sengkang General Hospital · NCT06363253 · Data updated 2026-11-12
This study is trying to see how the bacteria and substances in our bodies relate to health and conditions like obesity and muscle loss by looking at samples from different people.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 21 Years to 99 Years |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | Sengkang General Hospital Academic / other |
| Locations | 1 site (Singapore) |
| Status | Recruiting |
| Started | August 14, 2023 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | May 15, 2025 |
| Trial ID | NCT06363253 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals who are obese, sarcopenic, or healthy controls without obesity or sarcopenia.
✕Probably not a fit
Patients with intestinal stomas or those unable to provide informed consent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort study aims to explore the role of the human metagenome and associated metabolites in health and various metabolic diseases, particularly obesity and sarcopenia. Participants will provide fecal, salivary, urine, serum, and mucosal samples for metagenomic sequencing and metabolite analysis. The study seeks to identify differences in the metagenome and metabolome across different health states, with the potential for future personalized therapeutic applications. A cohort of healthy controls will also be included for comparison.
Why it matters
Potential benefit: If successful, this study could lead to personalized treatment strategies for patients with metabolic disorders.
How similar studies have gone: While the approach of studying the metagenome in relation to metabolic diseases is gaining interest, this specific study's focus on non-bacteriome species and their metabolites is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria (obese cohort): * Obese (BMI\>27.5kg/m2) Inclusion Criteria (sarcopenic cohort): * Sarcopenic patients, defined as 1) low handgrip strength (\<26 for males; \<18kg for females), AND/OR low gait speed (\<0.8m/s) AND low muscle mass (\<7.0kg/m2 for males; \<5.7kg/m2 for females) Inclusion Criteria (control cohort): \- Healthy subjects without sarcopenia, and not obese (BMI\<27.5kg/m2) Exclusion Criteria: * No informed consent * Presence of intestinal stoma, hence inability to collect fecal samples
Where it's running
-
Sengkang General Hospital
Singapore, Singapore Recruiting
Study contacts
- Study coordinator: Koy Min Chue
- Email: chue.koy.min@singhealth.com.sg
- Phone: 69305000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients
This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.
-
Investigating nutritional and environmental factors in elderly health
This study is trying to find out how nutrition and the environment affect the health of older people living in Nanshan to help prevent diseases like high blood pressure and diabetes.
-
GLP-1 receptor agonist use and muscle health in adults with obesity without diabetes
This study tests whether GLP-1 receptor agonists affect muscle mass and strength in adults with obesity who don’t have diabetes.
-
Sarcopenia After Bariatric Surgery: Changes in Muscle and Function
This study tests how bariatric surgery affects muscle mass, strength, and physical performance over time in adults undergoing the procedure.
-
Myokines in metabolic and endocrine diseases linked to sarcopenia
This study tests whether myokines can serve as biomarkers or drivers of sarcopenia and sarcopenic obesity in people with metabolic or endocrine diseases.
-
How obesity affects daily activities and physical abilities in older adults
This study tests how excess weight in people over 65 impacts daily tasks and physical performance, comparing obese seniors to normal-weight peers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.